AGT and cardiac hypertrophy: As showed in Figure 1A, the mRNA levels of FKBP12.6 were down‐regulated by 29% in hearts of WT mice after AngII infusion for 14 days, suggesting that FKBP12.6 might play a critical role in AngII‐induced cardiac hypertrophy.